The medical community is intrigued by retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing impressive results in clinical research. This compound works by replicating natural hormones to affect appetite and increase feelings of satiety, ultimately leading noticeable body decrease. While presently under evaluation and not broadly a